Redo Endoscopic Coronary Artery Bypass Grafting Authors: Tommaso Hinna Danesi Published: 2026 ABSTRACT Corresponding AuthorKey words: coronary artery bypass grafting, endoscopic conduit harvest, internal mammary artery, minimally invasive cardiac surgery, mini-thoracotomy, redo cardiac surgery Redo cardiac surgery is among the most technically demanding scenarios in cardiothoracic practice, and the decision to reoperate on patients with prior thoracic or cardiac surgical history demands careful individualization. These patients are frequently older, harbor substantial comorbidity burdens, and present with intrathoracic adhesions that transform routine anatomical planes into hazardous terrain—threatening previously placed bypass conduits, cardiac chambers, and great vessels on sternal re-entry.1 It is against this formidable backdrop that Görtzen et al2 present a timely and instructive case series of 6 patients who underwent redo endoscopic coronary artery bypass grafting (Endo-CAB), a sternal-sparing, minimally invasive approach to surgical coronary revascularization in the reoperative setting. The conventional therapeutic calculus in this population has long tilted toward percutaneous coronary intervention (PCI), favored for its lower short-term procedural risk compared with repeat median sternotomy. However, PCI carries well-recognized limitations in patients with left main coronary artery disease, advanced diffuse atherosclerosis, or anatomical complexity unfavorable for catheter-based treatment—precisely the patient profiles encountered in this series. Redo coronary artery bypass grafting (CABG) via repeat sternotomy addresses these anatomical constraints but at the cost of sternal re-entry injury, coagulopathy, prolonged recovery, and wound complications, with reported perioperative mortality rates of 3% to 7% and major morbidity exceeding 20% in high-risk subgroups.3 The series by Görtzen et al2 makes the case that minimally invasive surgery can occupy the middle ground between these 2 imperfect options. What is most instructive about this report is the breadth of prior surgical histories successfully navigated with a consistent operative framework. The 6 patients collectively represent previous pectus excavatum repair with caudal sternal turnover, posterolateral thoracotomy for pleurectomy, combined CABG and aortic valve replacement, prior Endo-CAB, isolated CABG with a nonfunctioning left internal mammary artery (LIMA) graft, and repeat aortic valve replacement for prosthetic endocarditis. Across these diverse cases, the authors applied a reproducible strategy: three 5-mm thoracoscopic ports; CO2 insufflation for enhanced visualization and pleural adhesiolysis; endoscopic conduit harvest, including right internal mammary artery harvest from the contralateral chest crossing the anterior mediastinum when ipsilateral access was precluded; and off-pump anastomosis through a mini-thoracotomy localized by the needle-based technique described by Ohtsuka et al.4 The choice of conduit (LIMA, right internal mammary artery, saphenous vein, or radial artery composite) was individualized to anatomical availability and prior interventions, reflecting the meticulous preoperative planning, including fractional flow reserve–guided coronary angiography and computed tomography assessment of conduit patency, aortic calcification, and adhesion burden, that underpins safe execution of this strategy. Two cases merit specific comment. In patient 1, childhood pectus excavatum repairs with caudal sternal turnover had resulted in bony overgrowth that rendered thoracoscopic LIMA harvest infeasible on intraoperative inspection. Rather than convert to sternotomy, the authors employed femoral extracorporeal circulatory support for pulmonary artery decompression and proximal aortic exposure, enabling a beating-heart saphenous vein graft to the left anterior descending coronary artery (LAD) through the mini-thoracotomy. In patient 6, in whom the only true redo Endo-CAB was performed following a prior Endo-CAB at the same institution, ventricular tachycardia during LIMA test clamping prompted conversion to extracorporeal support, and the procedure was completed uneventfully. These cases highlight both the importance of anticipating intraoperative contingencies and the feasibility of rescue strategies that preserve the sternal-sparing intent of the operation. All 6 patients had uncomplicated recoveries, with hospital discharge between postoperative days 3 and 14, and all achieved complete or significant resolution of anginal symptoms at follow-up. Notably, patient 4, who underwent a second redo procedure after 2 prior aortic valve replacements (EuroSCORE II 3.73), experienced postoperative nonsustained ventricular tachycardia that resolved during follow-up without requiring implantable cardioverter-defibrillator implantation. The 0% perioperative mortality and absence of sternal or major wound complications across the series, though derived from a small cohort in an experienced center, are encouraging and provide important proof-of-concept data. Several important limitations must be acknowledged, as the authors themselves do. This is a single-center, retrospective case series of 6 patients, precluding meaningful statistical inference or comparison with alternative strategies. Follow-up duration is not uniformly characterized, leaving long-term graft patency and freedom from repeat revascularization—the 2 outcomes that most distinguish surgical from percutaneous approaches—unquantified. The current series explicitly restricts redo Endo-CAB to single-vessel revascularization of the LAD; multivessel disease in the reoperative setting remains an indication for redo sternotomy at this institution. Critically, the reported outcomes reflect a program with substantial institutional experience in nonrobotic thoracoscopic LIMA harvest, a technique associated with a nontrivial learning curve even in the primary setting.5 Adoption of redo Endo-CAB outside experienced centers, and particularly in the reoperative context where intraoperative rescue options are constrained, should be approached with corresponding caution. The broader significance of this case series lies in the conceptual shift it represents: surgical revascularization in the reoperative patient need not be synonymous with repeat sternotomy. As minimally invasive and robotic coronary programs mature globally, prospective registry-based or multicenter matched analyses comparing redo Endo-CAB with PCI and conventional redo CABG—using graft patency imaging, health-related quality of life, and long-term major adverse cardiovascular events as end points—are needed to define the evidence base for this approach and its optimal patient selection criteria (Table 1). Table 1Redo Endo-CAB Versus Conventional Redo CABG via Repeat Median Sternotomy: Key Clinical ConsiderationsConsiderationConventional Redo CABGRedo Endo-CABSternal re-entryHigh risk—adhesions, vessel/graft injuryCompletely avoidedConduit harvestOpen; limited by prior LIMA useEndoscopic; contralateral IMA accessibleVisualizationRestricted by adhesionsCO2 insufflation; enhanced clarityBlood loss/transfusionIncreasedReducedPostoperative painSignificant; sternal instability riskReduced; intercostal analgesiaHospital stayTypically longerShorter (3-6 d in current series)Revascularization scopeMultivessel feasibleBest suited for single vessel (LAD)Long-term durabilityWell establishedExpected equivalent (IMA-LAD)CABG = coronary artery bypass grafting; Endo-CAB = endoscopic coronary artery bypass grafting; IMA = internal mammary artery; LAD = left anterior descending coronary artery; LIMA = left internal mammary artery. Redo Endo-CAB Versus Conventional Redo CABG via Repeat Median Sternotomy: Key Clinical Considerations CABG = coronary artery bypass grafting; Endo-CAB = endoscopic coronary artery bypass grafting; IMA = internal mammary artery; LAD = left anterior descending coronary artery; LIMA = left internal mammary artery. In the interim, the report by Görtzen et al2 provides a valuable addition to the reoperative coronary surgery literature and should prompt heart teams at experienced minimally invasive centers to formally incorporate redo Endo-CAB into their reoperative decision algorithms. These 6 carefully selected cases demonstrate that with meticulous planning and skilled execution, the sternum need not be re-entered to restore durable blood flow to the LAD. Funding Support and Author Disclosures The author has reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The author attests they are in compliance with human studies committees and animal welfare regulations of the author’s institution and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. References